| AAN | Aristolochic acid toxic nephropathy |
| AKI | Acute kidney injury |
| APC | Anaphase-promoting complex |
| ATM | Ataxia telangiectasia mutated protein |
| ATR | Ataxia telangiectasia and Rad3-related protein |
| CCN2 | Connective tissue growth factor 2 |
| cdc25 | Cell division cycle 25 |
| CDK | Cyclin-dependent kinase |
| CHK | Checkpoint kinase |
| CIP | CDK2 interacting protein |
| CKD | Chronic kidney disease |
| CKI | Cyclin-dependent kinase inhibitor |
| Col I | Collagen 1 |
| CTGF | Connective tissue growth factor 2 |
| CVD | Cardiovascular disease |
| CXCR2 | C-X-C motif chemokine receptor |
| DDR | DNA-damage response |
| E2F | E2 transcription factor |
| ECM | Extracellular matrix |
| EGFR | Epidermal growth factor receptor |
| FAN1 | Fanconi anemia-associated nuclease 1 |
| FDA | Food and drug administration |
| GFR | Glomerular filtration rate |
| IL-8 | Interleukin-8 |
| INK4 | Inhibitors of CDK4 |
| IRI | Ischemia-reperfusion injury |
| JNK | c-Jun NH2-terminal kinase |
| KDIGO | Kidney disease: Improving global outcomes |
| KIP | Kinase inhibiting protein |
| MAPK | Mitogen-activated protein kinase |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-κβ | Nuclear factor kappa beta |
| PTBA | 4-phenylthiol-butanoic acid |
| PTC | Proximal tubular epithelium cell |
| Rb | Retinoblastoma protein |
| ROS | Reactive oxygen species |
| SASP | Senescent associated secretory phenotype |
| TGFβ | Transforming growth factor beta |
| UUO | Unilateral ureteric obstruction |